Treating Achondroplasia

Um blog dedicado ao tratamento da acondroplasia. A blog dedicated to the treatment of achondroplasia. Un blog dedicado al tratamiento de la acondroplasia.

Páginas

  • Home
  • Index (EN)
  • Index (PT)
  • Index (ES)
  • Referências / References
  • Support & Information
  • Research
  • Glossary (EN)
  • Glossário (PT)
  • Glosario (ES)

Monday, February 29, 2016

The Rare Disease Day 2016

http://www.rarediseaseday.org/





Posted by Morrys C. Kaisermann at 7:48 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: Rare Disease Day
Newer Posts Older Posts Home
View mobile version
Subscribe to: Posts (Atom)
"Knowing is not enough; we must apply.
Willing is not enough; we must do."
Goethe

“Be the change that you wish to see in the world.”
Gandhi

Translator - Choose your Language

Introdução - Introduction - Introducción

Este é um blog Português - Inglês - Espanhol cujo objetivo é divulgar o conhecimento atual e as linhas de pesquisa básica e pesquisa clínica para o tratamento farmacológico da acondroplasia.

This is a Portuguese - English - Spanish blog directed to divulge the current knowledge and the basic and clinical research towards pharmacological therapies for achondroplasia.

Este es un blog Portugués - Inglés - Español cuyo objetivo es difundir el conocimiento actual y las líneas de investigación básica e investigación clínica para el tratamiento farmacológico de la acondroplasia.

This is a shorter link for this blog.

  • Treating Achondroplasia

Visits

Search This Blog

Search Clinical Trials (US, EU, Australia)

  • ANZCTR Australia Clinical Trial Registry
  • ClinicalTrials.gov (US)
  • EU Clinical Trials register

Pesquisa PubMed - PubMed Query

  • PubMed

Publicações do Autor - Papers by the Author

  • International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia (2022)
  • Poster presented during the American Society of Human Genetics Meeting 2012, San Francisco, US (Nov 2012)
  • Letter to Journal of Bone and Joint Surgery (British volume), Mar 2012
  • Letter to Science TM, Oct 2011
  • Letter to the Journal Bone, Mar 2011

Investigadores - Investigators

  • Dr. Jeffrey Baron (US)
  • Dr. Frank Beier Lab (Canada)
  • Dr. Kalina Hristova Lab (US)
  • Dr. Pavel Krejci Lab (Czechia)
  • Dr. Henry Kronenberg Lab (US)
  • Dr. Laurence Legeai-Mallet (France)
  • Dr. Efrat Monsonego Ornan Lab (Israel)
  • Dr. Geert Mortier - Growth Disorders (Belgium)
  • Dr. Ola Nilsson Lab, Karolinska Institutet (Sweden)
  • Dr. David Ornitz Lab (US)
  • Dr. Ravi Savarirayan (Australia)
  • Dr. Ernestina Schipani Lab (US)
  • Dr. Joseph Schlessinger Lab (US)
  • Dr. Andrea Superti-Furga (Lausanne University, Switzerland)
  • Dr. Andrea Vortkamp Lab (Germany) (some pages in German)
  • Dr. William Wilcox Lab (US)
  • Dr. Andrew Wilkie Lab (UK)
  • Dr. Avner Yayon Lab - ProCore Biomed (Israel)

Links - Relevant information

  • Achondroplasia in Facebook
  • Fundación Alpe (Spain)
  • Growing Stronger (US)
  • The Chandler Project
  • Hospital Garrahan - Argentina
  • National Institutes of Health (US)
  • OCD - Displasias Esqueléticas Brasil
  • Serviços de Genética Médica no Brasil
  • Little People of America Medical Resources
  • Swedish Information Center for Rare Diseases

Popular Posts

  • Treating achondroplasia: where we are now
    A bit of the basics There have passed 20 years since the identification of the cause of achondroplasia. We now understand that achondropla...
  • CNP, the first potential pharmacological therapy for achondroplasia
    Under great expectations, parents and relatives of children bearing the fibroblast growth factor receptor 3 (FGFR3) mutation causing ...
  • Treating achondroplasia: thirty months with vosoritide
    News On October 18th, during the R&D Day (or Analyst Day) event held in New York, Biomarin released the 30 month follow up data from...
  • Stopping FGFR3 production to treat achondroplasia (part 1)
    Introduction This blog currently has 24 followers ( that's what Google tells me...). These resilient readers likely think I repeat th...
  • Treating achondroplasia: concepts and misconcepts about the potential therapies in development
    The first potential therapy to treat the bone growth arrest in achondroplasia, the C-type natriuretic peptide (CNP) analogue BMN-111, is rea...

Growing Stronger - US

Growing Stronger - US

Fundación Alpe - Spain

Fundación Alpe - Spain

The Chandler Project

The Chandler Project

OCD (Brazil)

OCD (Brazil)

Raríssimas (Portugal)

Raríssimas (Portugal)

ANDO - Portugal

ANDO - Portugal

RE(ACT)

RE(ACT)

Arquivo - Archive

  • ►  2023 (1)
    • ►  April (1)
  • ►  2022 (3)
    • ►  November (1)
    • ►  October (1)
    • ►  February (1)
  • ►  2021 (6)
    • ►  November (2)
    • ►  August (1)
    • ►  July (1)
    • ►  January (2)
  • ►  2020 (4)
    • ►  February (2)
    • ►  January (2)
  • ►  2019 (14)
    • ►  November (2)
    • ►  October (2)
    • ►  July (1)
    • ►  June (5)
    • ►  March (2)
    • ►  January (2)
  • ►  2018 (24)
    • ►  December (2)
    • ►  October (2)
    • ►  July (2)
    • ►  May (2)
    • ►  April (1)
    • ►  March (8)
    • ►  February (6)
    • ►  January (1)
  • ►  2017 (6)
    • ►  December (2)
    • ►  October (1)
    • ►  August (1)
    • ►  March (1)
    • ►  January (1)
  • ▼  2016 (23)
    • ►  December (1)
    • ►  October (4)
    • ►  September (2)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  April (3)
    • ►  March (3)
    • ▼  February (1)
      • The Rare Disease Day 2016
    • ►  January (6)
  • ►  2015 (36)
    • ►  November (3)
    • ►  October (2)
    • ►  September (1)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (6)
    • ►  April (1)
    • ►  March (5)
    • ►  January (6)
  • ►  2014 (37)
    • ►  December (6)
    • ►  November (1)
    • ►  August (3)
    • ►  July (2)
    • ►  June (3)
    • ►  May (3)
    • ►  March (3)
    • ►  February (6)
    • ►  January (10)
  • ►  2013 (80)
    • ►  December (8)
    • ►  November (4)
    • ►  October (6)
    • ►  September (21)
    • ►  July (5)
    • ►  June (4)
    • ►  May (8)
    • ►  April (4)
    • ►  March (1)
    • ►  February (4)
    • ►  January (15)
  • ►  2012 (104)
    • ►  December (6)
    • ►  November (11)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (8)
    • ►  June (8)
    • ►  May (17)
    • ►  April (1)
    • ►  March (3)
    • ►  February (17)
    • ►  January (11)

Quem sou eu

Morrys C. Kaisermann
Morrys C. Kaisermann, médico com especial interesse nas displasias ósseas associadas à mutações do FGFR3, das quais a ACONDROPLASIA é a forma mais comum.
View my complete profile

Who I am

Morrys Kaisermann, physician interested in the study of the FGFR3-related chondrodysplasias and especially in the most common presentation, ACHONDROPLASIA.

Tags

Acondroplasia (193) CNP (121) English (121) Português (113) Achondroplasia (111) BMN-111 (103) Español (100) Drug Development (88) Biomarin (84) Desenvolvimento de medicações (61) Desarollo de medicamentos (56) PTH (21) Growth plate (19) MK-4 (14) Decoy (12) CosmoB (9) OCD (3)

Followers
Morrys C Kaisermann, M.D., Ph.D.. Simple theme. Powered by Blogger.